These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 30054496)
21. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics. Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981 [TBL] [Abstract][Full Text] [Related]
22. Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and p73. Hoshino M; Qi ML; Yoshimura N; Miyashita T; Tagawa K; Wada Y; Enokido Y; Marubuchi S; Harjes P; Arai N; Oyanagi K; Blandino G; Sudol M; Rich T; Kanazawa I; Wanker EE; Saitoe M; Okazawa H J Cell Biol; 2006 Feb; 172(4):589-604. PubMed ID: 16461361 [TBL] [Abstract][Full Text] [Related]
23. Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease. Ribeiro FM; Paquet M; Ferreira LT; Cregan T; Swan P; Cregan SP; Ferguson SS J Neurosci; 2010 Jan; 30(1):316-24. PubMed ID: 20053912 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway. Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672 [TBL] [Abstract][Full Text] [Related]
25. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539 [TBL] [Abstract][Full Text] [Related]
26. S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells. Li Y; Kong F; Wang J; Hu E; Wang R; Liu J; Xiao Q; Zhang W; He D; Xiao X Oncotarget; 2016 Jun; 7(25):38133-38142. PubMed ID: 27203549 [TBL] [Abstract][Full Text] [Related]
27. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096 [TBL] [Abstract][Full Text] [Related]
28. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells. Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291 [TBL] [Abstract][Full Text] [Related]
29. The regulation and function of YAP transcription co-activator. Zhu C; Li L; Zhao B Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920 [TBL] [Abstract][Full Text] [Related]
30. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863 [TBL] [Abstract][Full Text] [Related]
31. Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP. Palamiuc L; Johnson JL; Haratipour Z; Loughran RM; Choi WJ; Arora GK; Tieu V; Ly K; Llorente A; Crabtree S; Wong JCY; Ravi A; Wiederhold T; Murad R; Blind RD; Emerling BM Sci Signal; 2024 May; 17(838):eado6266. PubMed ID: 38805583 [TBL] [Abstract][Full Text] [Related]
32. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma. LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415 [TBL] [Abstract][Full Text] [Related]
33. Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells. Perumal N; Perumal M; Kannan A; Subramani K; Halagowder D; Sivasithamparam N Exp Cell Res; 2017 Jun; 355(2):124-141. PubMed ID: 28366538 [TBL] [Abstract][Full Text] [Related]
34. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway. Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643 [TBL] [Abstract][Full Text] [Related]
35. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Chen Q; Zhang N; Xie R; Wang W; Cai J; Choi KS; David KK; Huang B; Yabuta N; Nojima H; Anders RA; Pan D Genes Dev; 2015 Jun; 29(12):1285-97. PubMed ID: 26109051 [TBL] [Abstract][Full Text] [Related]
36. Hippo-YAP signaling pathway: A new paradigm for cancer therapy. Ma Y; Yang Y; Wang F; Wei Q; Qin H Int J Cancer; 2015 Nov; 137(10):2275-86. PubMed ID: 25042563 [TBL] [Abstract][Full Text] [Related]
37. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes. Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475 [TBL] [Abstract][Full Text] [Related]
38. Hippo signaling dysfunction induces cancer cell addiction to YAP. Han H; Yang B; Nakaoka HJ; Yang J; Zhao Y; Le Nguyen K; Bishara AT; Mandalia TK; Wang W Oncogene; 2018 Dec; 37(50):6414-6424. PubMed ID: 30068939 [TBL] [Abstract][Full Text] [Related]
39. The Hippo pathway member Nf2 is required for inner cell mass specification. Cockburn K; Biechele S; Garner J; Rossant J Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728 [TBL] [Abstract][Full Text] [Related]
40. Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression. Zhao Y; Chen Y; Guo C; Li P; Cheng Z; Zheng L; Sha B; Xu H; Su X; Wang Y Theranostics; 2024; 14(9):3653-3673. PubMed ID: 38948066 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]